Delivery Order SPE2DR25D2104-SPE2DR26F3RCB
- Not listed
- The Defense Logistics Agency awarded a $1,910.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit-dose 3 mL vials. The order was competitively awarded without set-aside designation and is scheduled for completion by December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,310.25 for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of August 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,226.87 to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on November 24, 2025, with an ultimate completion date of November 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose 3 mL vials, with a ceiling value of $8,823.72. This non-competitive delivery order was awarded on August 11, 2025, with an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract employs firm fixed price pricing and represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $13,916.52 delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 ml solution in unit-dose vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) calls for the pharmaceutical distributor to deliver the medication to its Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $1,973.31 delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit-dose 3 mL vials on August 8, 2025, with completion targeted for August 11, 2025. This firm fixed-price contract represents a non-set-aside competitive award supporting federal medical procurement needs. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a primary...
- The Defense Logistics Agency awarded a $1,670.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL Solution in unit dose vials. The order, issued on August 18, 2025, with completion targeted for August 19, 2025, represents a pharmaceutical supply delivery supporting federal medical procurement needs. This delivery order is classified as a child contract under AmerisourceBergen's broader federal contracting relationship and involves no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,528.21 to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 mL solution in unit dose vials. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion on August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a...
- The Defense Logistics Agency awarded a $2,623.02 delivery order to AmerisourceBergen Drug Corp for Yupelri (ipratropium bromide) 175 mcg/3 mL solution in unit dose vials on October 29, 2025, with an ultimate completion date of October 30, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement through the company's existing Indefinite Delivery...
- This delivery order, valued at $23,434.10 with a firm fixed price, was awarded on December 10, 2025, to AmerisourceBergen Drug Corp for the supply of Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. The contract is non-set-aside and competitively awarded, with performance to be completed by December 11, 2025, at the company's facility in Conshohocken, Pennsylvania. The Defense Logistics Agency, which operates under the Department of Defense, is the funding federal agency for this...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3RCBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,320.12 to AmerisourceBergen Drug Corp for Yupelri 175 mcg/3 ml solution in unit dose 3 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and pharmaceutical distribution operations. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical supply vendor, AmerisourceBergen leverages this prime IDV to supply pharmaceuticals and medical commodities to military healthcare systems, the Defense Health Agency, and other federal customers globally. The current order for Yupelri, a bronchodilator medication, represents a routine fulfillment under this comprehensive pharmaceutical support vehicle that enables flexible procurement of drugs, vaccines, and medical supplies across multiple therapeutic domains to support military medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 12/9/25 |